# Salvage Oligometastasectomy and Radiation Therapy in Recurrent Prostate Cancer

> **NCT03796767** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **University of Utah** · enrollment: 20 (actual)

## Conditions studied

- Recurrent Prostate Carcinoma
- Metastatic Malignant Neoplasm in the Bone
- Metastatic Malignant Neoplasm in the Lymph Nodes
- Oligometastasis
- Prostate Adenocarcinoma
- PSA Failure

## Interventions

- **RADIATION:** Hypofractionated Radiation Therapy
- **RADIATION:** Intensity-Modulated Radiation Therapy
- **PROCEDURE:** Metastasectomy
- **OTHER:** Quality-of-Life Assessment
- **OTHER:** Questionnaire Administration
- **RADIATION:** Stereotactic Body Radiation Therapy

## Key facts

- **NCT ID:** NCT03796767
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-09-09
- **Primary completion:** 2024-02-13
- **Final completion:** 2026-06-30
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2026-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03796767

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03796767, "Salvage Oligometastasectomy and Radiation Therapy in Recurrent Prostate Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03796767. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*